For years, IMUNA PHARM, a.s. has supplied its products to various countries in Central and Eastern Europe, Russia, former Soviet Union states, countries of the former Yugoslavia and a number of Asian countries.
Our medicines are made available to end consumers – patients – through our foreign branches or in cooperation with our international partners in the following states: Slovakia, the Czech Republic, Poland, Hungary, Serbia, Bosnia and Herzegovina, Kosovo, Macedonia (FYROM), Bulgaria, Russia, Ukraine, Belarus, Georgia, Armenia, Azerbaijan, Kazakhstan, Uzbekistan, Vietnam, Laos and Cambodia.
As part of our strategy of strengthening our position on European markets, we are currently looking to focus on high-potential markets such as Brazil, Argentina, Turkey, Australia and other countries in Asia, the Middle East and North Africa.
Expanding our services to other international markets is a strategic priority for IMUNA PHARM, a.s. Utilizing the complementary effect in therapeutic areas allows us to enjoy a stronger and more effective form of cooperation with other players on international markets.
We build on our long-term positive experience, trust and mutual benefit in our current partnerships while remaining open to new forms of cooperation.
For more information on potential cooperation, please contact our Business Development Team.